Doxorubicin and trabectedin in leiomyosarcoma: pioneering a new era of smart combinations in soft tissue sarcomas

被引：0
作者：
Assi, Tarek [1 ,2 ]
Le Cesne, Axel [1 ,2 ]
机构：
[1] Gustave Roussy Canc Campus, Div Int Patients Care, 114 Rue Edouard Vaillant, F-94800 Villejuif, France
[2] Gustave Roussy Canc Campus, Med Oncol, Villejuif, France
来源：
FUTURE ONCOLOGY | 2025年 / 21卷 / 08期
关键词：
Sarcoma; leiomyosarcoma; doxorubicin; trabectedin; metastasis; standard of care; chemotherapy; RANDOMIZED PHASE-II; 1ST-LINE TREATMENT; UTERINE; MULTICENTER; IFOSFAMIDE; ET-743;
D O I：
10.1080/14796694.2025.2463881
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：879 / 882
页数：4
相关论文
共 24 条
[1]   A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma [J].
Assi, Tarek ;
Kattan, Joseph ;
El Rassy, Elie ;
Honore, Charles ;
Dumont, Sarah ;
Mir, Olivier ;
Le Cesne, Axel .
CANCER TREATMENT REVIEWS, 2019, 72 :37-44
[2]   Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma [J].
Blay, Jean-Yves ;
von Mehren, Margaret ;
Samuels, Brian L. ;
Fanucchi, Michael P. ;
Ray-Coquard, Isabelle ;
Buckley, Brigid ;
Gilles, Leen ;
Lebedinsk, Claudia ;
Elsayed, Yusri A. ;
Le Cesne, Axel .
CLINICAL CANCER RESEARCH, 2008, 14 (20) :6656-6662
[3]   Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group [J].
D'Ambrosio, Lorenzo ;
Touati, Nathan ;
Blay, Jean-Yves ;
Grignani, Giovanni ;
Flippot, Ronan ;
Czarnecka, Anna M. ;
Piperno-Neumann, Sophie ;
Martin-Broto, Javier ;
Sanfilippo, Roberta ;
Katz, Daniela ;
Duffaud, Florence ;
Vincenzi, Bruno ;
Stark, Daniel P. ;
Mazzeo, Filomena ;
Tuchscherer, Armin ;
Chevreau, Christine ;
Sherriff, Jenny ;
Estival, Anna ;
Litiere, Saskia ;
Sents, Ward ;
Ray-Coquard, Isabelle ;
Tolomeo, Francesco ;
Le Cesne, Axel ;
Rutkowski, Piotr ;
Stacchiotti, Silvia ;
Kasper, Bernd ;
Gelderblom, Hans ;
Gronchi, Alessandro .
CANCER, 2020, 126 (11) :2637-2647
[4]   Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules [J].
Demetri, George D. ;
Chawla, Sant P. ;
von Mehren, Margaret ;
Ritch, Paul ;
Baker, Laurence H. ;
Blay, Jean Y. ;
Hande, Kenneth R. ;
Keohan, Mary L. ;
Samuels, Brian L. ;
Schuetze, Scott ;
Lebedinsky, Claudia ;
Elsayed, Yusri A. ;
Izquierdo, Miguel A. ;
Gomez, Javier ;
Park, Youn C. ;
Le Cesne, Axel .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4188-4196
[5]   Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing [J].
Ducimetiere, Francoise ;
Lurkin, Antoine ;
Ranchere-Vince, Dominique ;
Decouvelaere, Anne-Valerie ;
Peoc'h, Michel ;
Istier, Luc ;
Chalabreysse, Philippe ;
Muller, Christine ;
Alberti, Laurent ;
Bringuier, Pierre-Paul ;
Scoazec, Jean-Yves ;
Schott, Anne-Marie ;
Bergeron, Christophe ;
Cellier, Dominic ;
Blay, Jean-Yves ;
Ray-Coquard, Isabelle .
PLOS ONE, 2011, 6 (08)
[6]   Soft Tissue and Uterine Leiomyosarcoma [J].
George, Suzanne ;
Serrano, Cesar ;
Hensley, Martee L. ;
Ray-Coquard, Isabelle .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (02) :144-+
[7]   Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial [J].
Judson, Ian ;
Verweij, Jaap ;
Gelderblom, Hans ;
Hartmann, Jorg T. ;
Schoeffski, Patrick ;
Blay, Jean-Yves ;
Kerst, J. Martijn ;
Sufliarsky, Josef ;
Whelan, Jeremy ;
Hohenberger, Peter ;
Krarup-Hansen, Anders ;
Alcindor, Thierry ;
Marreaud, Sandrine ;
Litiere, Saskia ;
Hermans, Catherine ;
Fisher, Cyril ;
Hogendoorn, Pancras C. W. ;
dei Tos, A. Paolo ;
van der Graaf, Winette T. A. .
LANCET ONCOLOGY, 2014, 15 (04) :415-423
[8]   Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial [J].
Le Cesne, Axel ;
Blay, Jean-Yves ;
Domont, Julien ;
Tresch-Bruneel, Emmanuelle ;
Chevreau, Christine ;
Bertucci, Francois ;
Delcambre, Corinne ;
Saada-Bouzid, Esma ;
Piperno-Neumann, Sophie ;
Bay, Jacques-Olivier ;
Mir, Olivier ;
Ray-Coquard, Isabelle ;
Ryckewaert, Thomas ;
Valentin, Thibaud ;
Isambert, Nicolas ;
Italiano, Antoine ;
Clisant, Stephanie ;
Penel, Nicolas .
LANCET ONCOLOGY, 2015, 16 (03) :312-319
[9]   Maintenance therapy and drug holiday in sarcoma patients: systematic review [J].
Lebellec, Loic ;
Defachelles, Anne-Sophie ;
Cren, Pierre-Yves ;
Penel, Nicolas .
ACTA ONCOLOGICA, 2020, 59 (09) :1084-1090
[10]   Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study [J].
Martin-Broto, Javier ;
Lopez Pousa, Antonio ;
de las Penas, Ramon ;
Garcia del Muro, Xavier ;
Gutierrez, Antonio ;
Martinez-Trufero, Javier ;
Cruz, Josefina ;
Alvarez, Rosa ;
Cubedo, Ricardo ;
Redondo, Andres ;
Maurel, Joan ;
Carrasco, Juan A. ;
Lopez-Martin, Jose A. ;
Sala, Angeles ;
Andres Meana, Jose ;
Ramos, Rafael ;
Martinez-Serra, Jordi ;
Lopez-Guerrero, Jose A. ;
Sevilla, Isabel ;
Balana, Carmen ;
Vaz, Angeles ;
De Juan, Ana ;
Alemany, Regina ;
Poveda, Andres .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) :2294-+
123